Academic Journals Database
Disseminating quality controlled scientific knowledge

Biologics : Targets & Therapy

ISSN: 1177--5475
Publisher: Dove Press


ADD TO MY LIST
 
NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]

Author(s): Lurati A | Bertani L | Marrazza M | Re KA | Bompane D | Scarpellini M
Volume: 2013
Issue: default
Year: 2013
Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis

Author(s): Mathieu S | Couderc M | Glace B | Pereira B | Tournadre A | Dubost JJ | Soubrier M
Volume: 2013
Issue: default
Year: 2013
Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus

Author(s): Ideno S | Sakai K | Yunoki M | Kubota-Koketsu R | Inoue Y | Nakamura S | Yasunaga T | Okuno Y | Ikuta K
Volume: 2013
Issue: default
Year: 2013
Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]

Author(s): Keohane C | Radia DH | Harrison CN
Volume: 2013
Issue: default
Year: 2013
Efficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck

Author(s): Yang H | Diao LQ | Shi M | Ma R | Wang JH | Li JP | Xiao F | Xue Y | Xu M | Zhou B
Volume: 2013
Issue: default
Year: 2013
Treatment and management of myelofibrosis in the era of JAK inhibitors

Author(s): Keohane C | Radia DH | Harrison CN
Volume: 2013
Issue: default
Year: 2013
Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus

Author(s): Pipattanaboon C | Sasaki T | Nishimura M | Setthapramote C | Pitaksajjakul P | Leaungwutiwong P | Limkittikul K | Puiprom O | Sasayama M | Chaichana P | Okabayashi T | Kurosu T | Ono K | Ramasoota P | Ikuta K
Volume: 2013
Issue: default
Year: 2013
Erythropoiesis stimulating agents approaches to modulate activity

Author(s): Sinclair AM
Volume: 2013
Issue: default
Year: 2013
A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease

Author(s): Bennett J | Dubois C
Volume: 2013
Issue: default
Year: 2013
Tivozanib in the treatment of renal cell carcinoma

Author(s): Hepgur M | Sadeghi S | Dorff TB | Quinn DI
Volume: 2013
Issue: default
Year: 2013
PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update

Author(s): Reuss R
Volume: 2013
Issue: default
Year: 2013
New and emerging treatments for ulcerative colitis: a focus on vedolizumab

Author(s): Gledhill T | Bodger K
Volume: 2013
Issue: default
Year: 2013
Hereditary angioedema: epidemiology, management, and role of icatibant

Author(s): Ghazi A | Grant JA
Volume: 2013
Issue: default
Year: 2013
Bosutinib in the management of chronic myelogenous leukemia

Author(s): Keller-von Amsberg G | Schafhausen P
Volume: 2013
Issue: default
Year: 2013
Clinical use of crizotinib for the treatment of non-small cell lung cancer

Author(s): Roberts PJ
Volume: 2013
Issue: default
Year: 2013
Cetuximab: its unique place in head and neck cancer treatment

Author(s): Specenier P | Vermorken JB
Volume: 2013
Issue: default
Year: 2013
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis

Author(s): Benucci M | Saviola G | Manfredi M | Sarzi-Puttini P | Atzeni F
Volume: 2013
Issue: default
Year: 2013
Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma

Author(s): Ansari J | Hussain SA | Ansari A | Glaholm J
Volume: 2013
Issue: default
Year: 2013
Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer

Author(s): D'Arcangelo M | Cappuzzo F
Volume: 2013
Issue: default
Year: 2013
Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents

Author(s): Ververis K | Hiong A | Karagiannis TC | Licciardi PV
Volume: 2013
Issue: default
Year: 2013
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib

Author(s): Nooka A | Gleason C | Casbourne D | Lonial S
Volume: 2013
Issue: default
Year: 2013
Treatment of hemophilia B: focus on recombinant factor IX

Author(s): Franchini M | Frattini F | Crestani S | Sissa C | Bonfanti C
Volume: 2013
Issue: default
Year: 2013
Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

Author(s): Cantini F | Niccoli L | Cassara E | Kaloudi O | Nannini C
Volume: 2013
Issue: default
Year: 2013
Clofilium inhibits Slick and Slack potassium channels

Author(s): Tejada MA | Stolpe K | Meinild AK | Klaerke DA
Volume: 2012
Issue: default
Year: 2012
Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis

Author(s): Thorlund K | Druyts E | Aviña-Zubieta JA | Mills EJ
Volume: 2012
Issue: default
Year: 2012
Limited cross-reactivity of mouse monoclonal antibodies against Dengue virus capsid protein among four serotypes

Author(s): Noda M | Masrinoul P | Punkum C | Pipattanaboon C | Ramasoota P | Setthapramote C | Sasaki T | Sasayama M | Yamashita A | Kurosu T | Ikuta K | Okabayashi T
Volume: 2012
Issue: default
Year: 2012
Potential role of 124I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer

Author(s): Smaldone MC | Chen DY | Yu JQ | Plimack ER
Volume: 2012
Issue: default
Year: 2012
Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update

Author(s): Wojciechowski D | Vincenti F
Volume: 2012
Issue: default
Year: 2012
Role of CD44 as a marker of cancer stem cells in head and neck cancer

Author(s): Trapasso S | Allegra E
Volume: 2012
Issue: default
Year: 2012
Clinical use of biologics in vasculitis syndromes

Author(s): Paroli M
Volume: 2012
Issue: default
Year: 2012
Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir

Author(s): D'Ambrosio R | Aghemo A | Colombo M
Volume: 2012
Issue: default
Year: 2012
Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection

Author(s): Ippoliti G | D'Armini AM | Lucioni M | Marjieh M | Viganò M
Volume: 2012
Issue: default
Year: 2012
B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab

Author(s): Wiesik-Szewczyk E | Olesinska M
Volume: 2012
Issue: default
Year: 2012
Lebrikizumab in the personalized management of asthma

Author(s): Thomson NC | Patel M | Smith AD
Volume: 2012
Issue: default
Year: 2012
The role of epigenetic mechanisms and processes in autoimmune disorders

Author(s): Greer JM | McCombe PA
Volume: 2012
Issue: default
Year: 2012
Emerging role of multikinase inhibitors for refractory thyroid cancer

Author(s): Perez CA | Arango BA | Velez M | Raez LE | Santos ES
Volume: 2012
Issue: default
Year: 2012
Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010

Author(s): Kubota-Koketsu R | Yunoki M | Okuno Y | Ikuta K
Volume: 2012
Issue: default
Year: 2012
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study

Author(s): Cantini F | Niccoli L | Cassarà E | Kaloudi O | Nannini C
Volume: 2012
Issue: default
Year: 2012
Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?

Author(s): Jones G | Darian-Smith E | Kwok M | Winzenberg T
Volume: 2012
Issue: default
Year: 2012
Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure

Author(s): Kekow J | Mueller-Ladner U | Schulze-Koops H
Volume: 2012
Issue: default
Year: 2012
The effect of erythropoietin on normal and neoplastic cells

Author(s): Elliott S | Sinclair AM
Volume: 2012
Issue: default
Year: 2012
Metastatic gastric cancer – focus on targeted therapies

Author(s): Meza-Junco J | Sawyer MB
Volume: 2012
Issue: default
Year: 2012
Ovarian cancer: emerging molecular-targeted therapies

Author(s): Sourbier C
Volume: 2012
Issue: default
Year: 2012
Natural killer cells: role in local tumor growth and metastasis

Author(s): Langers I | Renoux VM | Thiry M | Delvenne P | Jacobs N
Volume: 2012
Issue: default
Year: 2012
Gut microbiota: next frontier in understanding human health and development of biotherapeutics

Author(s): Prakash S | Rodes L | Coussa-Charley M | Tomaro-Duchesneau C
Volume: 2011
Issue: default
Year: 2011
Current neoadjuvant treatment options for HER2 positive breast cancer

Author(s): Abdel-Razeq H | Marei L
Volume: 2011
Issue: default
Year: 2011
Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions

Author(s): Almer G | Saba-Lepek M | Haj-Yahya S | Rohde E | Strunk D | Fröhlich E | Prassl R | Mangge H
Volume: 2011
Issue: default
Year: 2011
Role of vandetanib in the management of medullary thyroid cancer

Author(s): Brassard M | Rondeau G
Volume: 2012
Issue: default
Year: 2012
Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) – a review of a new treatment paradigm

Author(s): Heslet L | Nielsen JD | Nepper-Christensen S
Volume: 2012
Issue: default
Year: 2012
Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis

Author(s): Hasan E | Olusi S | Al-Awadhi A | Mokaddem K | Sharma P | George S
Volume: 2012
Issue: default
Year: 2012
Prevalence of OmpK35 and OmpK36 porin expression in beta-lactamase and non-beta-lactamase-producing Klebsiella pneumoniae

Author(s): Shakib P | Ghafourian S | Zolfaghary MR | Hushmandfar R | Ranjbar R | Sadeghifard N
Volume: 2012
Issue: default
Year: 2011
Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

Author(s): Cantini F | Niccoli L | Nannini C | Kaloudi O | Cassarà E | Susini M | Lenzetti I
Volume: 2012
Issue: default
Year: 2011
Eribulin mesylate in the treatment of metastatic breast cancer

Author(s): Jain S | Cigler T
Volume: 2012
Issue: default
Year: 2012
Monoclonal antibodies and Fc fragments for treating solid tumors

Author(s): Eisenbeis AM | Grau SJ
Volume: 2012
Issue: default
Year: 2012
OnabotulinumtoxinA in the treatment of neurogenic bladder

Author(s): Gulamhusein A | Mangera A
Volume: 2012
Issue: default
Year: 2012
A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex

Author(s): Stephen P Myers | Joan O'Connor | J Helen Fitton | et al
Volume: 2011
Issue: default
Year: 2011
Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus

Author(s): Michael Sticherling
Volume: 2011
Issue: default
Year: 2011
Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress

Author(s): Bibiana Garcia-Bailo | Ahmed El-Sohemy | Pierre S Haddad | et al
Volume: 2011
Issue: default
Year: 2011
Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug  Effectiveness Review Project

Author(s): Kylie Thaler | Divya V Chandiramani | Richard A Hansen | et al
Volume: 2009
Issue: default
Year: 2009
Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments

Author(s): Gesmar RS Segundo | Fabíola A Gomes | Karla P Fernandes | et al
Volume: 2009
Issue: default
Year: 2009
A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase

Author(s): Regina P El Dib | Gregory M Pastores
Volume: 2009
Issue: default
Year: 2009
Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies

Author(s): Laith Altaweel | Daniel Sweeney | Xizhong Cui | et al
Volume: 2009
Issue: default
Year: 2009
Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy

Author(s): Bryan A Faller | Barbara Burtness
Volume: 2009
Issue: default
Year: 2009
Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers

Author(s): Jia Li | Muhammad Wasif Saif
Volume: 2009
Issue: default
Year: 2009
Review of the safety and efficacy of imiglucerase treatment of Gaucher disease

Author(s): Deborah Elstein | Ari Zimran
Volume: 2009
Issue: default
Year: 2009
Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi’s sarcoma

Author(s): Francesca Cainelli | Alfredo Vallone
Volume: 2009
Issue: default
Year: 2009
Finding a new drug and vaccine for emerging swine flu: What is the concept?

Author(s): Viroj Wiwanitkit
Volume: 2009
Issue: default
Year: 2009
Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID

Author(s): Claire Booth | H Bobby Gaspar
Volume: 2009
Issue: default
Year: 2009
Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation

Author(s): Junichiro Sageshima | Gaetano Ciancio | Linda Chen | George W Burke III
Volume: 2009
Issue: default
Year: 2009
Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature

Author(s): Jochen Schmitt | Gottfried Wozel
Volume: 2009
Issue: default
Year: 2009
HER2 breast cancer therapies: a review

Author(s): Conleth G Murphy | Shanu Modi
Volume: 2009
Issue: default
Year: 2009
Early stage and long term treatment of multiple sclerosis with interferon-β

Author(s): Angela Applebee | Hillel Panitch
Volume: 2009
Issue: default
Year: 2009
Potentials and limitations of microorganisms as renal failure biotherapeutics

Author(s): Poonam Jain | Sapna Shah | Razek Coussa | Satya Prakash
Volume: 2009
Issue: default
Year: 2009
Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells

Author(s): Arvind Kumar | Tryambak D Singh | Santosh K Singh | Satya Prakash
Volume: 2009
Issue: default
Year: 2009
B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis

Author(s): Joseph M Tuscano | Jacob Sands
Volume: 2009
Issue: default
Year: 2009
EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab

Author(s): Chad A Reade | Apar Kishor Ganti
Volume: 2009
Issue: default
Year: 2009
Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia

Author(s): Radhakrishnan Ramchandren | Charles A Schiffer
Volume: 2009
Issue: default
Year: 2009
Infliximab in the treatment of rheumatoid arthritis

Author(s): A Perdriger
Volume: 2009
Issue: default
Year: 2009
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency

Author(s): Irina Petrache | Joud Hajjar | Michael Campos
Volume: 2009
Issue: default
Year: 2009
Long-term pegylated interferon-α and its potential in the treatment of melanoma

Author(s): Reinhard Dummer | Joanna Mangana
Volume: 2009
Issue: default
Year: 2009
Treatment of immune thrombocytopenic purpura: focus on eltrombopag

Author(s): Lawrence Rice
Volume: 2009
Issue: default
Year: 2009
Management of chronic hepatitis C treatment failures: role of consensus interferon

Author(s): Stevan A Gonzalez | Emmet B Keeffe
Volume: 2009
Issue: default
Year: 2009
Challenges in the management of juvenile idiopathic arthritis with etanercept

Author(s): Clare E Pain | Liza J McCann
Volume: 2009
Issue: default
Year: 2009
Biologic targeting in the treatment of inflammatory bowel diseases

Author(s): Matteo Bosani | Sandro Ardizzone | Gabriele Bianchi Porro
Volume: 2009
Issue: default
Year: 2009
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency

Author(s): Caitriona McLean | Catherine M Greene | Noel G McElvaney
Volume: 2009
Issue: default
Year: 2009
Basiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years?

Author(s): Martina Koch | Thomas Becker | Rainer Lueck | Michael Neipp | Juergen Klempnauer | Bjoern Nashan
Volume: 2009
Issue: default
Year: 2009
Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia

Author(s): Eric Cheung | Howard A Liebman
Volume: 2009
Issue: default
Year: 2009
Maintenance treatment with infliximab for the management of Crohn’s disease in adults

Author(s): Renato Caviglia | Ivo Boškoski | Michele Cicala
Volume: 2009
Issue: default
Year: 2009
Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model

Author(s): Markus Scholz | Manuela Ackermann | Frank Emmrich | Markus Loeffler | Manja Kamprad
Volume: 2009
Issue: default
Year: 2008
Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer

Author(s): Bernadette Biondi | Melania Pulcrano | Loredana Pagano | Gaetano Lombardi
Volume: 2009
Issue: default
Year: 2008
Front line treatment of elderly multiple myeloma in the era of novel agents

Author(s): Marie-Dominique Venon | Aldo M Roccaro | Julie Gay | Anne-Sophie Moreau | Remy Dulery | et al
Volume: 2009
Issue: default
Year: 2008
Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines

Author(s): Aruna Chandran | Sean Fitzwater | Anjie Zhen | et al
Volume: 2010
Issue: default
Year: 2010
Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent

Author(s): Peter Reimer | Rolf Vosshenrich
Volume: 2010
Issue: default
Year: 2010
Proteasome inhibition and its therapeutic potential in multiple myeloma

Author(s): Ajai Chari | Amitabha Mazumder | Sundar Jagannath
Volume: 2010
Issue: default
Year: 2010
Bevacizumab in the treatment of ovarian cancer

Author(s): Ramez N Eskander | Leslie M Randall
Volume: 2011
Issue: default
Year: 2011
The role of stem cells in tumor targeting and growth suppression of gliomas

Author(s): Eskandary H | Basiri M | Nematollahi-Mahani SN | Mehravaran S
Volume: 2011
Issue: default
Year: 2011
An update on belimumab for the treatment of lupus

Author(s): Aikaterini Thanou-Stavraki | Amr H Sawalha
Volume: 2011
Issue: default
Year: 2011
Targeted therapy in melanoma

Author(s): Hussein Tawbi | Neelima Nimmagadda
Volume: 2009
Issue: default
Year: 2009
Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis

Author(s): Damiano Paolicelli | Vita Direnzo | Maria Trojano
Volume: 2009
Issue: default
Year: 2009
First-line treatment of acute lymphoblastic leukemia with pegasparaginase

Author(s): Riccardo Masetti | Andrea Pession
Volume: 2009
Issue: default
Year: 2009
The old and new therapeutic approaches to the treatment of giardiasis: Where are we?

Author(s): Haendel GNO Busatti | Joseph FG Santos | Maria A Gomes
Volume: 2009
Issue: default
Year: 2009
Palifermin for management of treatment-induced oral mucositis in cancer patients

Author(s): Andrei Barasch | Joel Epstein | Ken Tilashalski
Volume: 2009
Issue: default
Year: 2009
Current available therapies and future directions in the treatment of malignant gliomas

Author(s): Annick Desjardins | David A Reardon | James J Vredenburgh
Volume: 2009
Issue: default
Year: 2008
Botulinum toxin type A in the treatment of patients with cervical dystonia

Author(s): Allison Brashear
Volume: 2009
Issue: default
Year: 2008
Management of patients with advanced non-small cell lung cancer: role of gefitinib

Author(s): Vamsidhar Velcheti | Daniel Morgensztern | Ramaswamy Govindan
Volume: 2010
Issue: default
Year: 2010
Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle

Author(s): Andreas Rank | Oliver Weigert | Helmut Ostermann
Volume: 2010
Issue: default
Year: 2010
Potential role of ustekinumab in the treatment of chronic plaque psoriasis

Author(s): Santo Raffaele Mercuri | Luigi Naldi
Volume: 2010
Issue: default
Year: 2010
The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer

Author(s): Mohamedtaki A Tejani | Roger B Cohen | Ranee Mehra
Volume: 2010
Issue: default
Year: 2010
Use of clofarabine for acute childhood leukemia

Author(s): A Pession | R Masetti | K Kleinschmidt | et al
Volume: 2010
Issue: default
Year: 2010
Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies

Author(s): Yuan Li | Janine A Burns | Carol A Cheney | et al
Volume: 2010
Issue: default
Year: 2010
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection

Author(s): J Paul Frindik | Stephen F Kemp
Volume: 2010
Issue: default
Year: 2010
New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride

Author(s): Cary O Harding
Volume: 2010
Issue: default
Year: 2010
New and emerging treatment approaches to lupus

Author(s): Marion Haubitz
Volume: 2010
Issue: default
Year: 2010
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer

Author(s): William Boland | Gwyn Bebb
Volume: 2010
Issue: default
Year: 2010
Safety of etanercept in elderly subjects with rheumatoid arthritis

Author(s): Alfredomaria Lurati | Mariagrazia Marrazza | Katia Angela | et al
Volume: 2010
Issue: default
Year: 2009
Ustekinumab in the therapy of chronic plaque psoriasis

Author(s): Jenna L O’Neill | Robert E Kalb
Volume: 2009
Issue: default
Year: 2009
A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis

Author(s): Stephen P Myers | Joan O’Connor | J Helen Fitton | et al.
Volume: 2010
Issue: default
Year: 2010
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib

Author(s): Richard Quek | Suzanne George
Volume: 2010
Issue: default
Year: 2010
Recombinant follitropin alfa/lutropin alfa in fertility treatment

Author(s): Ahmed Gibreel | Siladitya Bhattacharya
Volume: 2010
Issue: default
Year: 2009
Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model

Author(s): Brent Sorenson | Kaysie Banton | Lance Augustin | et al
Volume: 2010
Issue: default
Year: 2010
Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer

Author(s): Jaclyn Flanigan | Hari Deshpande | Scott Gettinger
Volume: 2010
Issue: default
Year: 2010
Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins

Author(s): Mohamed Mahdi-Rogers | Yusuf A Rajabally
Volume: 2010
Issue: default
Year: 2010
Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency

Author(s): Sabine Kroiss | Manuela Albisetti
Volume: 2010
Issue: default
Year: 2010
Palliative treatment of malignant ascites: profile of catumaxomab

Author(s): Lila Ammouri | Eric E Prommer
Volume: 2010
Issue: default
Year: 2010
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma

Author(s): Peter E Clark
Volume: 2010
Issue: default
Year: 2010
Decreasing glioma recurrence through adjuvant cancer stem cell inhibition

Author(s): Josh Neman | Rahul Jandial
Volume: 2010
Issue: default
Year: 2010
Abatacept in difficult-to-treat juvenile idiopathic arthritis

Author(s): Jasmin B Kuemmerle-Deschner | SM Benseler
Volume: 2008
Issue: Issue 4
Year: 2009
Therapeutic vaccines for malignant brain tumors

Author(s): Michael P Gustafson | Keith L Knutson | Allan B Dietz
Volume: 2008
Issue: Issue 4
Year: 2008
Denileukin diftitox for the treatment of cutaneous T-cell lymphoma

Author(s): David Kaminetzky | Kenneth B Hymes
Volume: 2008
Issue: Issue 4
Year: 2008
Bevacizumab in the treatment of HER2-negative breast cancer

Author(s): Vito Lorusso
Volume: 2008
Issue: Issue 4
Year: 2008
Association of pro/anti-inflammatory cytokine gene variants in renal transplant patients with allograft outcome and cyclosporine immunosuppressant levels

Author(s): Parmeet Kaur Manchanda | Anant Kumar | Raj K Sharma | Himanshu Goel | Rama Devi Mittal
Volume: 2008
Issue: Issue 4
Year: 2008
Effect of extended-release niacin on hormone-sensitive lipase and lipoprotein lipase in patients with HIV-associated lipodystrophy syndrome

Author(s): Dominic C Chow | Anne Tasaki | Jill Ono | Bruce Shiramizu | Scott A Souza
Volume: 2008
Issue: Issue 4
Year: 2008
Sorafenib for the treatment of unresectable hepatocellular carcinoma

Author(s): Junji Furuse
Volume: 2008
Issue: Issue 4
Year: 2008
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease

Author(s): Fernando C Fervenza | Roser Torra | David G Warnock
Volume: 2008
Issue: Issue 4
Year: 2008
Efalizumab-induced severe thrombocytopenia can be resolved

Author(s): Francesca Prignano | F Zanieri | S Mokhtarzadeh | T Lotti
Volume: 2008
Issue: Issue 4
Year: 2008
Rituximab therapy in Greek patients with rheumatoid arthritis

Author(s): Aristotelis P Tsiakalos | Nestor K Avgoustidis | Haralampos M Moutsopoulos
Volume: 2008
Issue: Issue 4
Year: 2008
Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy

Author(s): Maristella D’Uva | Pierpaolo Di Micco | Ida Strina | Antonio Ranieri | Carlo Alviggi | et al
Volume: 2008
Issue: Issue 4
Year: 2008
Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap)

Author(s): Leigh D Church | Sinisa Savic | Michael F McDermott
Volume: 2008
Issue: Issue 4
Year: 2008
Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies

Author(s): Steven J Greco | Pranela Rameshwar
Volume: 2008
Issue: Issue 4
Year: 2008
Small molecule tyrosine kinase inhibitors in pancreatic cancer

Author(s): Sachin Gupta | Bassel F El-Rayes
Volume: 2008
Issue: Issue 4
Year: 2008
Review of consensus interferon in the treatment of chronic hepatitis C

Author(s): Th Witthöft
Volume: 2008
Issue: Issue 4
Year: 2008
Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFα therapy

Author(s): Hubert Marotte | Pierre Miossec
Volume: 2008
Issue: Issue 4
Year: 2008
α-L-iduronidase therapy for mucopolysaccharidosis type I

Author(s): Jakub Tolar | Paul J Orchard
Volume: 2008
Issue: Issue 4
Year: 2008
Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines

Author(s): Faten Merhi | Jacques Auger | Francine Rendu | Brigitte Bauvois
Volume: 2008
Issue: Issue 4
Year: 2008
Biological drugs targeting the immune response in the therapy of psoriasis

Author(s): Saveria Pastore | Emanuela Gubinelli | Luca Leoni | Desanka Raskovic | Liudmila Korkina
Volume: 2008
Issue: Issue 4
Year: 2008
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma

Author(s): Camillo Porta | Chiara Paglino | Luciano Mutti
Volume: 2008
Issue: Issue 4
Year: 2008
Clinical use of topical thrombin as a surgical hemostat

Author(s): Wesley K Lew | Fred A Weaver
Volume: 2008
Issue: Issue 4
Year: 2008
The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer

Author(s): Masahide Matsuyama | Rikio Yoshimura
Volume: 2008
Issue: Issue 4
Year: 2008
Anticomplement therapy

Author(s): Prathit A Kulkarni | Vahid Afshar-Kharghan
Volume: 2008
Issue: Issue 4
Year: 2009
Novel microtubule-targeting agents – the epothilones

Author(s): Kit L Cheng | Thomas Bradley | Daniel R Budman
Volume: 2008
Issue: Issue 4
Year: 2008
Rituximab in the treatment of non-Hodgkin’s lymphoma

Author(s): Beate Hauptrock | Georg Hess
Volume: 2008
Issue: Issue 4
Year: 2008
The insulin-like growth factor system and its receptors: A potential novel anticancer target

Author(s): Colin R. Lindsay | T R Jeffry Evans
Volume: 2008
Issue: Issue 4
Year: 2008
Adalimumab for the treatment of Crohn’s disease

Author(s): Andrea Cassinotti | Sandro Ardizzone | Gabriele Bianchi Porro
Volume: 2008
Issue: Issue 4
Year: 2008
Denosumab: an investigational drug for the management of postmenopausal osteoporosis

Author(s): E Michael Lewiecki
Volume: 2008
Issue: Issue 4
Year: 2008
IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts

Author(s): Mathieu C Tamby | Amélie Servettaz | Nicolas Tamas | Joseph Reinbolt | Frédéric Caux | et al
Volume: 2008
Issue: Issue 3
Year: 2008
T20QoL: an observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy

Author(s): R Bucciardini | M Massella | A Corpolongo | P Narciso | V Fragola | et al
Volume: 2008
Issue: Issue 3
Year: 2008
The antidiabetic effects of a dry powder of dietary vegetable and fruit mixtures in diabetic db/db mice

Author(s): Chung-Man Yeung | Yi Tan | Sidney Tam | Liwei Lu | King-Hung Ko | et al
Volume: 2008
Issue: Issue 3
Year: 2008
Analysis and variability of TGFβ measurements in cancer patients with skeletal metastases

Author(s): Peter J O’Brien | Rajeev Ramanathan | Jonathan M Yingling | Jose Baselga | Mace L Rothenberg | et al
Volume: 2008
Issue: Issue 3
Year: 2008
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer

Author(s): Eduardo Lasalvia-Prisco | Emilio Garcia-Giralt | Jesús Vázquez | Marta Aghazarian | Eduardo Lasalvia-Galante | et al
Volume: 2008
Issue: Issue 3
Year: 2008
Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer

Author(s): Shannon Puhalla | Adam Brufsky
Volume: 2008
Issue: Issue 3
Year: 2008
New treatment options in the management of IBD – focus on colony stimulating factors

Author(s): Josué Barahona-Garrido | Jesús K Yamamoto-Furusho
Volume: 2008
Issue: Issue 3
Year: 2008
Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia

Author(s): Judith E Karp | Jeffrey E Lancet
Volume: 2008
Issue: Issue 3
Year: 2008
Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action

Author(s): Lina Nordquist | Fredrik Palm | Bradley T Andresen
Volume: 2008
Issue: Issue 3
Year: 2008
Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias

Author(s): Aldo M Roccaro | Irene M Ghobrial | Simona Blotta | Steven P Treon | Michele Malagola | et al
Volume: 2008
Issue: Issue 3
Year: 2008
Top-down or bottom-up: Contrasting perspectives on psychiatric diagnoses

Author(s): Willem MA Verhoeven | Siegfried Tuinier | Ineke van der Burgt
Volume: 2008
Issue: Issue 3
Year: 2008
Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures

Author(s): Neil Ghodadra | Kern Singh
Volume: 2008
Issue: Issue 3
Year: 2008
Functional and gene expression analysis of hTERT overexpressed endothelial cells

Author(s): Haruna Takano | Satoshi Murasawa | Takayuki Asahara
Volume: 2008
Issue: Issue 3
Year: 2008
Novel targets for immunotherapy in glomerulonephritis

Author(s): Mary H Foster
Volume: 2008
Issue: Issue 3
Year: 2008
Targeted therapies in the management of renal cell carcinoma: role of bevacizumab

Author(s): Bernard Escudier | Jan Cosaert | Sangeeta Jethwa
Volume: 2008
Issue: Issue 3
Year: 2008
Lepirudin in the management of patients with heparin-induced thrombocytopenia

Author(s): Sirak Petros
Volume: 2008
Issue: Issue 3
Year: 2008
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel®

Author(s): Ferdin | Roelfsema | Nienke R Biermasz | Alberto M Pereira | Johannes A Romijn
Volume: 2008
Issue: Issue 3
Year: 2008
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants

Author(s): Asunción Mejías | Octavio Ramilo
Volume: 2008
Issue: Issue 3
Year: 2008
Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside

Author(s): Ana Villegas | Fernando A Gonzalez | Leopoldo Llorente | Santiago Redondo
Volume: 2008
Issue: Issue 3
Year: 2008
The role of B cells in systemic sclerosis

Author(s): Marina D Kraaij | Jacob M van Laar
Volume: 2008
Issue: Issue 3
Year: 2008
Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells

Author(s): Satya Prakash | Aleksandra Malgorzata Urbanska
Volume: 2008
Issue: Issue 3
Year: 2008
Infliximab in ulcerative colitis

Author(s): Avi Levin | Oren Shibolet
Volume: 2008
Issue: Issue 3
Year: 2008
Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses

Author(s): Yong-Hong Yi | Wen-Chao Guo | Wei-Wen Sun | Tao Su | Han Lin | et al
Volume: 2008
Issue: Issue 2
Year: 2008
Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition

Author(s): Bostjan Humar | Les McNoe | Anita Dunbier | Rosemary Heathcott | Antony W Braithwaite | Anthony E Reeve
Volume: 2008
Issue: Issue 2
Year: 2008
Cognitive performance and the thymus among HIV-infected subjects receiving HAART

Author(s): Maria J Miguez-Burbano | John E Lewis | Jose Moreno | Joel Fishman
Volume: 2008
Issue: Issue 2
Year: 2008
Natalizumab in the treatment of Crohn’s disease

Author(s): Danila Guagnozzi | Renzo Caprilli
Volume: 2008
Issue: Issue 2
Year: 2008
Strategies for regenerating injured axons after spinal cord injury – insights from brain development

Author(s): Masaki Ueno | Toshihide Yamashita
Volume: 2008
Issue: Issue 2
Year: 2008
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences

Author(s): Matthew L Stoll | Alisa C Gotte
Volume: 2008
Issue: Issue 2
Year: 2008
Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents

Author(s): Antonio M Risitano | Bruno Rotoli
Volume: 2008
Issue: Issue 2
Year: 2008
Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance

Author(s): Jennifer S Carew | Steffan T Nawrocki | Francis J Giles | John L Cleveland
Volume: 2008
Issue: Issue 2
Year: 2008
Natalizumab for the treatment of relapsing multiple sclerosis

Author(s): Richard A Rudick | Michael A Panzara
Volume: 2008
Issue: Issue 2
Year: 2008
The role of basiliximab in the evolving renal transplantation immunosuppression protocol

Author(s): Paola Salis | Chiara Caccamo | Roberto Verzaro | Salvatore Gruttadauria | Mary Artero
Volume: 2008
Issue: Issue 2
Year: 2008
Update on the use of etanercept across a spectrum of rheumatoid disorders

Author(s): Bernard Combe
Volume: 2008
Issue: Issue 2
Year: 2008
Mycophenolate mofetil in the treatment of lupus nephritis

Author(s): Patrick FK Yong | David P D’Cruz
Volume: 2008
Issue: Issue 2
Year: 2008
Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab

Author(s): George P Kim | Axel Grothey
Volume: 2008
Issue: Issue 2
Year: 2008
Selenium and thyroid autoimmunity

Author(s): Roberto Negro
Volume: 2008
Issue: Issue 2
Year: 2008
The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia

Author(s): Terry Golombick | Terry Diamond
Volume: 2008
Issue: Issue 1
Year: 2008
Activity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the inhibition of adhesion molecule expression on human umbilical vascular endothelial cells

Author(s): Torsten Hans Schroeder | Wolfgang Artur Krueger | Hans-Jürgen Dieterich | Boris Nohé
Volume: 2008
Issue: Issue 1
Year: 2008
Garlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL

Author(s): Greg Hodge | Stephen Davis | Michael Rice | Heather Tapp | Ben Saxon | Tamas Revesz
Volume: 2008
Issue: Issue 1
Year: 2008
Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)

Author(s): Andrea Pession | Fraia Melchionda | Claudia Castellini
Volume: 2008
Issue: Issue 1
Year: 2008
Infliximab for the treatment of plaque psoriasis

Author(s): Jennifer S Gall | Robert E Kalb
Volume: 2008
Issue: Issue 1
Year: 2008
Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer

Author(s): Archana Monie | Chien-Fu Hung | Richard Roden | T-C Wu
Volume: 2008
Issue: Issue 1
Year: 2008
Sunitinib for advanced renal cell cancer

Author(s): Chris Coppin
Volume: 2008
Issue: Issue 1
Year: 2008
Erlotinib in the treatment of advanced pancreatic cancer

Author(s): Robin K Kelley | Andrew H Ko
Volume: 2008
Issue: Issue 1
Year: 2008
Review of tocilizumab in the treatment of rheumatoid arthritis

Author(s): Yasuaki Okuda
Volume: 2008
Issue: Issue 1
Year: 2008
Current and future applications of the anti-IgE antibody omalizumab

Author(s): Cristoforo Incorvaia | Marina Mauro | Gian Galeazzo Riario-Sforza | Franco Frati | Francesco Tarantini | Maurizio Caserini
Volume: 2008
Issue: Issue 1
Year: 2008
Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer

Author(s): Bella Kaufman | Steven Stein | Michelle A Casey | Beth O Newstat
Volume: 2008
Issue: Issue 1
Year: 2008
Bevacizumab in the therapy for refractory metastatic colorectal cancer

Author(s): Mary F Mulcahy
Volume: 2008
Issue: Issue 1
Year: 2008
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)

Author(s): Marco Montillo | Francesca Ricci | Sara Miqueleiz | Alessandra Tedeschi | Enrica Morra
Volume: 2008
Issue: Issue 1
Year: 2008
Abciximab: a reappraisal of its use in coronary care

Author(s): Marco Valgimigli | Gianluca Campo | Matteo Tebaldi | Roberto Carletti | Chiara Arcozzi | et al
Volume: 2008
Issue: Issue 1
Year: 2008
Clinical uses of GM-CSF, a critical appraisal and update

Author(s): Martha Arellano | Sagar Lonial
Volume: 2008
Issue: Issue 1
Year: 2008
A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers

Author(s): Robert C Fang | Robert D Galiano
Volume: 2008
Issue: Issue 1
Year: 2008
Why do you need a reservation system?      Affiliate Program